VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Legend Biotech Corporation (LEGN) Total Return Calculator with Dividends Reinvested

Legend Biotech Corporation

Popular:

The total return for Legend Biotech Corporation (LEGN) stock is -7.68% over the past 12 months. So far it's up 34.64% this year. The 5-year total return is +4.02%, meaning $10,000 invested in LEGN stock 5 years ago would be worth $10,402 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in LEGN 1 year ago, it would be worth $9,202 today — you'd have lost $798.

With Dividends Reinvested$9,202-7.98%

Price Only (No DRIP)$9,202-7.98%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in LEGN

1Y$9,232-$768 (-7.7%)-7.7% CAGR

3Y$4,213-$5,787 (-57.9%)-25.0% CAGR

5Y$10,402+$402 (+4.0%)0.8% CAGR

10Y$7,827-$2,173 (-21.7%)-2.4% CAGR

15Y$7,827-$2,173 (-21.7%)-1.6% CAGR

20Y$7,827-$2,173 (-21.7%)-1.2% CAGR

30Y$7,827-$2,173 (-21.7%)-0.8% CAGR

Legend Biotech Corporation did not pay dividends during this period. Total return = price return.

Loading LEGN total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+34.64%	—	+34.64%	—	$13,464
1Y	-7.68%	-7.68%	-7.68%	—	$9,232
3Y	-57.87%	-25.03%	-57.87%	—	$4,213
5Y	+4.02%	0.79%	+4.02%	—	$10,402
10Y	-21.73%	-2.42%	-21.73%	—	$7,827
15Y	-21.73%	-1.62%	-21.73%	—	$7,827
20Y	-21.73%	-1.22%	-21.73%	—	$7,827
30Y	-21.73%	-0.81%	-21.73%	—	$7,827

Risk & Highlights

Best Year+66.52%2021

Worst Year-44.94%2024

Max Drawdown-62.43%2025-07-23 → 2026-02-04

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-11.67%	-11.67%	—	+0.41%	-12.1pp
2025	-37.40%	-37.40%	—	+16.64%	-54.0pp
2024	-44.94%	-44.94%	—	+24.00%	-68.9pp
2023	+23.55%	+23.55%	—	+24.81%	-1.3pp
2022	+3.61%	+3.61%	—	-19.95%	+23.6pp

LEGN underperformed the S&P 500 by 39.01pp over the past year (-7.68% vs +31.32%).

Loading summary...

LEGN Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
LEGNLegend Biotech Corporation	$5.3B	+55.0%	+34.6%	-7.7%	—	-57.9%	+4.0%	-21.7%
FATEFate Therapeutics, Inc.	$264M	+92.4%	+131.3%	+139.1%	—	-58.0%	-97.0%	+33.9%
CRSPCRISPR Therapeutics AG	$5.3B	+12.1%	+2.4%	+66.1%	—	-1.6%	-48.9%	+290.9%
BEAMBeam Therapeutics Inc.	$3.3B	+33.4%	+19.1%	+102.2%	—	-3.0%	-53.9%	+72.4%
NTLAIntellia Therapeutics, Inc.	$1.6B	+4.1%	+50.4%	+91.0%	—	-67.9%	-79.2%	-37.3%
EDITEditas Medicine, Inc.	$311M	+16.7%	+54.9%	+138.7%	—	-67.0%	-90.8%	-89.5%
BMYBristol-Myers Squibb Company	$115.4B	-4.7%	+8.1%	+24.1%	+5.3pp	-6.7%	+5.6%	+7.3%
ALNYAlnylam Pharmaceuticals, Inc.	$40.4B	-8.3%	-24.3%	+12.3%	—	+44.3%	+129.4%	+445.5%
SRPTSarepta Therapeutics, Inc.	$2.4B	+1.0%	+8.1%	-50.7%	—	-81.8%	-69.1%	+30.1%
IONSIonis Pharmaceuticals, Inc.	$12.7B	+3.4%	-3.5%	+141.2%	—	+118.4%	+105.9%	+126.0%
RCUSArcus Biosciences, Inc.	$2.6B	+16.9%	+11.6%	+220.2%	—	+31.0%	-13.7%	+52.9%

Compare:LEGN vs FATE LEGN vs CRSP LEGN vs BEAM LEGN vs FATE vs CRSP

About LEGN Dividend Returns

Legend Biotech Corporation (LEGN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of LEGN over the past year?

Legend Biotech Corporation (LEGN) delivered a return of -7.68% over the past year. Since LEGN does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in LEGN be worth today?

A $10,000 investment in Legend Biotech Corporation one year ago would be worth $9,232 today, representing a loss of $768.

Q3Does LEGN pay dividends?

Legend Biotech Corporation (LEGN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For LEGN, the total return equals the price-only return.

Q4Did LEGN beat the S&P 500?

No, Legend Biotech Corporation (LEGN) underperformed the S&P 500 by 39.01 percentage points over the past year. LEGN delivered a total return of -7.68%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed LEGN by 39.01pp during this period.

Q5What is LEGN's worst drawdown?

Legend Biotech Corporation (LEGN) experienced a maximum drawdown of -62.43% over the past year, declining from its peak on 2025-07-23 to its trough on 2026-02-04. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is LEGN's long-term total return over 10, 20, or 30 years?

Here are Legend Biotech Corporation (LEGN)'s long-term returns with dividends reinvested. Over 10 years, the total return is -21.7% (-2.4% CAGR) — $10,000 would have grown to $7,827. Over 20 years: -21.7% total return (-1.2% CAGR) — $10,000 → $7,827. Over 30 years: -21.7% total return (-0.8% CAGR) — $10,000 → $7,827. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was LEGN's best and worst year?

Legend Biotech Corporation's best calendar year was 2021 with a total return of 66.5%. Its worst year was 2024 with a total return of -44.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 111.5 percentage points.